| 000 | 00989 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250512051647.0 | ||
| 264 | 0 | _c19880817 | |
| 008 | 198808s 0 0 eng d | ||
| 022 | _a0006-2952 | ||
| 024 | 7 |
_a10.1016/0006-2952(88)90032-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKamen, B A | |
| 245 | 0 | 0 |
_aHigh dose methotrexate therapy: insecure rationale? _h[electronic resource] |
| 260 |
_bBiochemical pharmacology _cJul 1988 |
||
| 300 |
_a2713-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aDrug Resistance |
| 650 | 0 | 4 | _aFolic Acid Antagonists |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aThymidylate Synthase _xanalysis |
| 700 | 1 | _aWinick, N J | |
| 773 | 0 |
_tBiochemical pharmacology _gvol. 37 _gno. 14 _gp. 2713-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0006-2952(88)90032-9 _zAvailable from publisher's website |
| 999 |
_c3401084 _d3401084 |
||